| First Author | Crompton RA | Year | 2022 |
| Journal | J Invest Dermatol | Volume | 142 |
| Issue | 4 | Pages | 1206-1216.e8 |
| PubMed ID | 34710388 | Mgi Jnum | J:327481 |
| Mgi Id | MGI:7257671 | Doi | 10.1016/j.jid.2021.09.009 |
| Citation | Crompton RA, et al. (2022) An Epidermal-Specific Role for Arginase1 during Cutaneous Wound Repair. J Invest Dermatol 142(4):1206-1216.e8 |
| abstractText | Nonhealing wounds are a major area of unmet clinical need remaining problematic to treat. Improved understanding of prohealing mechanisms is invaluable. The enzyme arginase1 (ARG1) is involved in prohealing responses, with its role in macrophages best characterized. ARG1 is also expressed by keratinocytes; however, ARG1 function in these critical wound repair cells is not understood. We characterized ARG1 expression in keratinocytes during normal cutaneous repair and reveal de novo temporal and spatial expression at the epidermal wound edge. Interestingly, epidermal ARG1 expression was decreased in both human and murine delayed healing wounds. We therefore generated a keratinocyte-specific ARG1-null mouse model (K14-cre;Arg1(fl/fl)) to explore arginase function. Wound repair, linked to changes in keratinocyte proliferation, migration, and differentiation, was significantly delayed in K14-cre;Arg1(fl/fl) mice. Similarly, using the arginase inhibitor N(omega)-hydroxy-nor-L-arginine, human in vitro and ex vivo models further confirmed this finding, revealing the importance of the downstream polyamine pathway in repair. Indeed, restoring the balance in ARG1 activity through the addition of putrescine proved beneficial in wound closure. In summary, we show that epidermal ARG1 plays, to our knowledge, a previously unreported intrinsic role in cutaneous healing, highlighting epidermal ARG1 and the downstream mediators as potential targets for the therapeutic modulation of wound repair. |
